SARCOPENIA IS AN INDEPENDENT PROGNOSTIC FACTOR IN ELDERLY MALE PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: RESULTS FROM A MULTICENTER EXPERIENCE

Vittorio Ruggero Zilioli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alessandra Tucci(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Doriana Gramegna(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Manuela Camalori(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesco Merli(Azienda Sanitaria Unità Locale di Reggio Emilia), Luigi Marcheselli(University of Modena and Reggio Emilia), M. Manicone(University of Modena and Reggio Emilia), Giulia Besutti(University of Modena and Reggio Emilia), Cristina Muzi(Azienda Socio Sanitaria Territoriale Lariana), Domenico Albano(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Giuseppe Colloca(Agostino Gemelli University Polyclinic), Annalisa Arcari(Azienda Unità Sanitaria Locale Piacenza), Alessandra Coppola(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda)
Hematological Oncology
June 1, 2021
10.1002/hon.116_2880
Cited by 0

Related Papers

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage
|Blood|2008|253
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy
|Journal of Clinical Oncology|2017|196
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
|Blood|2010|189